Day 2, November 21, 2025 - ET (Eastern Time, GMT-05:00)
Explore the complex landscape of compliance considerations surrounding AI implementation in patient support programs. This session addresses key regulatory challenges, data protection concerns and best practices for maintaining ethical standards while leveraging AI technologies.
Examine the current regulatory framework governing AI use in healthcare and patient support
Discuss strategies for ensuring data privacy and security in AI-driven patient interactions
Explore methods for maintaining transparency and patient trust in AI-augmented services
- Erica Powers - Vice President, Chief Compliance Officer, Sage Therapeutics
Analyze the strategic benefits of incorporating patient ambassadors into your PSP, the potential risks associated and best practices for implementation
Examine the unique compliance challenges posed by patient influencers and explore strategies for monitoring and managing user-generated content
Explore how to be innovative with patient engagement with a compliance-driven approach
- Kari Loeser - Vice President, Chief Compliance Officer, Cytokinetics
- Kelley Medeiros - Compliance Officer, Neuromodulation, LivaNova Plc.
The alignment of access, legal/compliance and patient services is essential in creating programs that are productive, meaningful and patient centric. Benchmark with colleagues on the best practices that can be instated in each of the respective departments in order to create and foster a relationship that is collaborative, mutualistic and working toward the common goal of helping the patient.
- Chrissy Bradshaw - Senior Director, Brand and Compliance Counsel, Rocket Pharmaceuticals
In today's landscape, manufacturers face mounting pressure to deliver value while also ensuring that treatments remain accessible. During this session, explore innovative strategies to navigate gross-to-net while keeping patients at the center.
- Develop actionable frameworks for negotiating contracts that prioritize patient access while managing costs
- Mitigate the impact of industry challenges like benefit design complexity, accumulator programs and 340B changes
- Uncover methods to quantify and communicate the value of patient-centered GTN approaches to key stakeholders
As you tirelessly work to ensure that your support services are innovative, high touch and patient-centric, it is essential for patients and HCPs to be aware of the resources that you are offering to maximize adherence. During this session, uncover strategies to educate the various stakeholders of your programs to broaden reach, increase utilization and enhance outcome through amplified communication.
Define the key components in deciding on an external partner(s), including how to redefine your RFP process to be less transactional and more relational
Learn best practices in vendor collaboration and management, including how to work cross functionally in a way that is mutually beneficial
Uncover strategies to manage transition between vendors, outlining what that process looks like and how to identify any red flags or gaps in partnership
As we approach the one-year mark of the new administration, this session examines the evolving healthcare landscape and its impact on patient support programs. Industry experts will explore how shifting priorities and regulatory changes are reshaping the patient services ecosystem, offering insights to adapt to this dynamic environment.
Analyze key healthcare policies and initiatives affecting patient services, including drug pricing reforms and accessibility measures
Discuss the implications of policy changes on digital health integration and patient support strategies
Explore innovative models for patient assistance that align with emerging healthcare priorities
Develop agile approaches to future-proof patient support programs in a rapidly changing landscape
Examine the potential impact of proposed tariffs on pharmaceutical imports, including their effects on drug prices, supply chain resilience and efforts to reshore manufacturing to the U.S.
- Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
- Kristin Manzolillo - Senior Director and Team Lead, US Oncology Patient Solutions Strategy, Pfizer
This session explores the rapidly evolving landscape of accumulators, maximizers and alternative funding programs, examining their impact on patient affordability and manufacturer strategies. Attendees will gain insights into emerging tactics and learn how to navigate the complex regulatory environment.
Analyze the future trajectory of accumulator and maximizer programs in light of potential regulatory changes
Explore emerging cost-shifting strategies employed by payers and PBMs
Examine the growing patchwork of state laws affecting copay programs
Discuss risk mitigation strategies to ensure long-term sustainability of patient support initiatives
- Anna Hyde - Vice President of Advocacy and Access, Arthritis Foundation
In this closed door summit, benchmark with industry peers on best practices for risk mitigation, payer negotiations and patient support program design as cost sharing programs continue to disrupt the marketplace.
**Attendance for this session is limited and RSVP is required. To secure a spot, please email callie.mertel@informa.com. Attendance is at the discretion of Informa Connect.
Join industry leaders for an insightful panel discussion exploring the nuances of patient support programs across large, mid-size and small pharmaceutical companies. This session will delve into the unique challenges, opportunities and best practices for each company size, providing valuable benchmarking insights for attendees.
Explore in-house vs. outsourced models for different company scales
Examine technology adoption and digital solutions across different company sizes
Discussing strategies for maintaining a patient-centric approach regardless of scale and explore innovative engagement techniques for companies with limited resources
Examine how patient support programs evolve as companies grow
Explore the transformative potential of digital therapeutics (DTx) in enhancing patient support programs and improving health outcomes. This cutting-edge session delves into the integration of evidence-based digital interventions within the patient care journey, offering insights into the latest trends, best practices and future directions of DTx in patient support.st
Understand the fundamentals of digital therapeutics and their role in modern patient support strategies
Explore the regulatory landscape and approval processes for digital therapeutics
Discuss strategies for seamless integration of DTx into existing patient support programs
Analyze the impact of digital therapeutics on patient engagement, adherence and outcomes
Forecast future trends and innovations in the digital therapeutics space
Join us for an engaging benchmarking session that delves into the latest trends and strategies reshaping patient access and patient services. Explore key metrics, best practices and innovative approaches that are driving success in these critical areas. Gain valuable insights from industry leaders and benchmark your organization's performance against industry standards to uncover new opportunities for growth and improvement.